March 12, 2005
The Harvard Business School Journal Working Knowledge recently published an interview with Michael Kremer and Rachel Glennerster discussing "pull mechanisms" to encourage commercial vaccine R&D efforts for developing countries. Many of the points reflected in the interview are discussed in the authors' new book Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases.
"With pull programs, money changes hands only after a successful product is developed, thus giving researchers strong incentives to self-select projects that have the best chance of success."Kremer served as Co-Director of the CGD working group which is publishing "Making Markets for Vaccines".
CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.